Open access · US-GOV via ClinicalTrials.gov Clinical trial

Pilot Study of Brentuximab Vedotin in CD30 Positive EBV Positive Diffuse Large B-Cell Lymphomas of the Elderly

Authors not listed

H. Lee Moffitt Cancer Center and Research Institute · 2013

Dysbiosis Human Randomized controlled trial

Abstract

The main purpose of this study is to test if brentuximab vedotin has an effect on cancer in patients with a certain type of large B-Cell Lymphoma. The side effects (unwanted effects) of SGN-35 in patients with this certain type of large B-Cell Lymphoma will also be studied. It is not known if brentuximab vedotin is better or worse than other treatment that might be given.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-19 MST

Cite this

APA

Anonymous. (2013). Pilot Study of Brentuximab Vedotin in CD30 Positive EBV Positive Diffuse Large B-Cell Lymphomas of the Elderly. <em>H. Lee Moffitt Cancer Center and Research Institute</em>. https://clinicaltrials.gov/study/NCT01671813

Vancouver

Anonymous. Pilot Study of Brentuximab Vedotin in CD30 Positive EBV Positive Diffuse Large B-Cell Lymphomas of the Elderly. H. Lee Moffitt Cancer Center and Research Institute. 2013.

BibTeX

@misc{anon2013PilotS, title = {Pilot Study of Brentuximab Vedotin in CD30 Positive EBV Positive Diffuse Large B-Cell Lymphomas of the Elderly}, author = {Anonymous}, journal = {H. Lee Moffitt Cancer Center and Research Institute}, year = {2013}, }